Our white paper, "Breaking the GLP-1 Cost Cycle," explores the complexities of the obesity crisis and reveals two innovative solutions designed to improve health outcomes and generate savings for employers
In cancer cells, NNT activity is stimulated by hyperpolarized mitochondria
Back in 2005, a company called AstraZeneca came up with a new idea
Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials
Some protocols begin with a brief intensive phase (for example, daily or alternate-day dosing) followed by a maintenance phase (for example, weekly to monthly), particularly for B12 deficiency
Our results highlight the need to design innovative weightmaintenance programs to reduce the longterm cost burden, Kim said